2TRZ - 10mg

Tirzepatide is a dual GIP and GLP-1 receptor agonist studied for its effects on appetite regulation, glucose metabolism, insulin sensitivity, and body-weight reduction. Research has shown significant potential for weight management and metabolic health, with studies examining reductions in body weight, improved glycemic control, and changes in fat mass.

Research Areas:

Appetite and satiety regulation

Body-weight and fat-mass reduction

Glucose and insulin metabolism

Insulin sensitivity

Metabolic health and energy balance